Dialytic therapy for irreversible uremia (first of two parts).

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Histamine (first of two parts).

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

Bronchodilator therapy (second of two parts).

Enzymology of cancer cells (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Binding of drugs to serum albumin (first of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Insulin metabolism in chronic uremia and in the anephric state: effect of the dialytic treatment.

Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management.

Vasodilator therapy of cardiac failure (second of two parts).

Pragmatic realities in uremia therapy.

The complexity of dialytic therapy in hyperammonemic neonates.

Gastrin (second of two parts).

Histamine (second of two parts).

Noninvasive cardiac diagnosis (first of three parts).

Abdominal surgery (first of three parts).

Suggest Documents

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Histamine (first of two parts).

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

Bronchodilator therapy (second of two parts).

Enzymology of cancer cells (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Binding of drugs to serum albumin (first of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Insulin metabolism in chronic uremia and in the anephric state: effect of the dialytic treatment.

Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management.

Vasodilator therapy of cardiac failure (second of two parts).

Pragmatic realities in uremia therapy.

The complexity of dialytic therapy in hyperammonemic neonates.

Gastrin (second of two parts).

Histamine (second of two parts).

Noninvasive cardiac diagnosis (first of three parts).

Abdominal surgery (first of three parts).

Dialytic therapy for irreversible uremia (first of two parts).

Recommend Documents

Follow Us